Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Jinar RostamiAnna Erlandsson

Abstract

Many lines of evidence suggest that the Parkinson's disease (PD)-related protein α-synuclein (α-SYN) can propagate from cell to cell in a prion-like manner. However, the cellular mechanisms behind the spreading remain elusive. Here, we show that human astrocytes derived from embryonic stem cells actively transfer aggregated α-SYN to nearby astrocytes via direct contact and tunneling nanotubes (TNTs). Failure in the astrocytes' lysosomal digestion of excess α-SYN oligomers results in α-SYN deposits in the trans-Golgi network followed by endoplasmic reticulum swelling and mitochondrial disturbances. The stressed astrocytes respond by conspicuously sending out TNTs, enabling intercellular transfer of α-SYN to healthy astrocytes, which in return deliver mitochondria, indicating a TNT-mediated rescue mechanism. Using a pharmacological approach to inhibit TNT formation, we abolished the transfer of both α-SYN and mitochondria. Together, our results highlight the role of astrocytes in α-SYN cell-to-cell transfer, identifying possible pathophysiological events in the PD brain that could be of therapeutic relevance.SIGNIFICANCE STATEMENT Astrocytes are the major cell type in the brain, yet their role in Parkinson's disease progression r...Continue Reading

Citations

May 16, 2018·Cellular and Molecular Life Sciences : CMLS·Didier VilettePascal Leblanc
Feb 27, 2018·Cell and Tissue Research·Jennifer A SteinerPatrik Brundin
Jul 31, 2018·Traffic·Heiko Lemcke, Robert David
Jul 26, 2018·Annual Review of Cell and Developmental Biology·Albert A DavisDavid M Holtzman
Sep 13, 2018·Journal of Cellular Physiology·Rahul MittalVasanti M Jhaveri
Jan 17, 2019·Journal of Neuroscience Research·Alexei A Surguchev, Andrei Surguchov
May 12, 2018·Acta Neuropathologica Communications·Martin Timo HenrichWolfgang Hermann Oertel
May 29, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Jared T HinkleTed M Dawson
Mar 24, 2020·Nature Reviews. Neurology·Chao PengVirginia M-Y Lee
Nov 2, 2019·Cellular and Molecular Life Sciences : CMLS·Cecilia A BrunelloHenri J Huttunen
Jul 31, 2020·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Huimin ZhengYuming Xu
Sep 15, 2020·Neurotoxicity Research·Dario ValdinocciDean L Pountney
Oct 6, 2018·Cellular and Molecular Neurobiology·Gabriel GustafssonMartin Ingelsson
Jan 25, 2019·Translational Neurodegeneration·Shen-Zhao LuJia-Wei Zhou
Feb 25, 2019·Acta Neuropathologica·Zachary A SorrentinoParamita Chakrabarty
Apr 7, 2019·Molecular Neurodegeneration·Marie-Eve TremblayLaura Civiero
May 21, 2019·Frontiers in Molecular Neuroscience·Eftychia VasiliTiago Fleming Outeiro
Nov 7, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Wassilios G MeissnerOlivier Rascol
Sep 20, 2019·Life Science Alliance·Justine LempartUrsula Jakob
Jan 11, 2020·Frontiers in Bioengineering and Biotechnology·Beatrice FormicolaFrancesca Re
Jul 31, 2020·Cancer Reports·Varun Subramaniam Venkatesh, Emil Lou
Oct 7, 2018·Fluids and Barriers of the CNS·Mariella ErredeDaniela Virgintino
Dec 13, 2018·Neurology and Therapy·Samis M A ZellaLars Tönges
Jul 6, 2019·Frontiers in Neuroscience·Jiangnan MaAnmu Xie
May 22, 2019·Acta Neuropathologica Communications·Zuzana KrejciovaStanley B Prusiner
Oct 18, 2019·Frontiers in Neuroscience·Dario ValdinocciDean L Pountney
Apr 18, 2020·Journal of Neuroinflammation·Jinar RostamiAnna Erlandsson
Apr 3, 2020·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Srinivasa Subramaniam
Apr 4, 2019·Frontiers in Aging Neuroscience·Isadora MatiasFlávia Carvalho Alcantara Gomes
Feb 13, 2020·International Journal of Molecular Sciences·Fabiana NovellinoGiuseppe Donato
Jul 28, 2020·International Journal of Molecular Sciences·Ching-On Wong
Sep 26, 2020·Experimental & Molecular Medicine·Rachael H Earls, Jae-Kyung Lee
Jun 13, 2019·Molecular Neurodegeneration·Daniel Twohig, Henrietta M Nielsen
Nov 30, 2019·Frontiers in Molecular Neuroscience·Cameron WellsNitin K Saksena
Oct 20, 2020·Frontiers in Molecular Neuroscience·Maria MerezhkoHenri J Huttunen
Dec 3, 2020·Frontiers in Cell and Developmental Biology·Yu-Mi JeonHyung-Jun Kim
Jul 15, 2020·Neurobiology of Disease·Qingyun Li, Michael S Haney
Dec 30, 2020·Journal of Neurochemistry·Jennifer R PinnellKim Tieu
Feb 17, 2021·Signal Transduction and Targeted Therapy·Delin LiuJunjie Gao
Nov 3, 2020·Frontiers in Aging Neuroscience·Jessica TittelmeierCarmen Nussbaum-Krammer

❮ Previous
Next ❯

Methods Mentioned

BETA
protein assay
Assay
Tandem Sensor
transfection
confocal microscopy

Software Mentioned

IMARIS
Zen
Image Lab
GraphPad Prism
ImageJ

Related Concepts

Related Feeds

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.